Shenzhen Salubris Pharmaceuticals News

Shenzhen Salubris Pharmaceuticals: Announcement on the Progress of JK06 Overseas Clinical Trial

Aug 5 12:00 ET

Shenzhen Salubris Pharmaceuticals: Announcement on the approval of clinical trial notification for new indications of Enadastron.

Jul 31 12:00 ET

Shenzhen Salubris Pharmaceuticals: Announcement regarding the receipt of the clinical trial approval notice for SAL0120.

Jul 30 12:00 ET

Shenzhen Salubris Pharmaceuticals: Announcement on the completion of non-trading transfer and repurchase of shares for the third phase of employee stock ownership plan

Jul 11 12:00 ET

Shenzhen Salubris Pharmaceuticals: Announcement regarding the pharmaceutical registration certificate for Benzoic Acid Voglibose Tablets (Xinlitin)

Jul 5 12:00 ET

Shenzhen Salubris Pharmaceuticals: Announcement regarding the acceptance of the SAL056 listing application.

Jun 25 12:00 ET

Shenzhen Salubris Pharmaceuticals: Asset management contract for Guolian Salubris No. 3 Employee Shareholding Single Asset Management Plan.

Jun 21 12:00 ET

Shenzhen Salubris Pharmaceuticals: Announcement Regarding the Release of Pledged Shares by the Controlling Shareholder.

Jun 20 12:00 ET

Shenzhen Salubris Pharmaceuticals: Announcement Regarding the Selection of the Management Committee for the Third Phase of Employee Stock Ownership Plan

Jun 20 12:00 ET

Shenzhen Salubris Pharmaceuticals: Notice of the expiration of the lock-up period for the second phase of employee shareholding plan.

Jun 17 12:00 ET

Shenzhen Salubris Pharmaceuticals: Announcement of Annual Equity Distribution Implementation in 2023

Jun 11 12:00 ET

Shenzhen Salubris Pharmaceuticals: Announcement regarding Sun Company providing guarantee for its subsidiary.

Jun 4 12:00 ET

Shenzhen Salubris Pharmaceuticals: Notice on obtaining a drug registration certificate for alisartan ester amlodipine tablets (foritan)

May 21 12:00 ET

Shenzhen Salubris Pharmaceuticals: Announcement on shareholders donating part of the company's shares free of charge

May 13 12:00 ET

Shenzhen Salubris Pharmaceuticals: Announcement on shareholders donating part of the company's shares free of charge to complete the transfer

May 7 12:00 ET

Shenzhen Salubris Pharmaceuticals: Announcement on the controlling shareholder's partial share pledge and cancellation of the pledge

May 5 12:00 ET

Xinlitai: First Quarter Report 2024

Apr 22 12:00 ET

Xinlitai: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

Apr 22 12:00 ET

Xinlitai: Announcement of Resolutions of the Third Meeting of the 6th Board of Directors

Apr 22 12:00 ET

Xinlitai: Announcement on capital increase for subsidiary Salubris Biotherapeutics, Inc.

Apr 22 12:00 ET